skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello,

I wanted to discuss Pfizer, a company with a dividend yield of 6%. Its yield and growth prospects appear more appealing than those of many other dividend stocks, including those in the telecommunication and utility sectors.

My question is: What is your opinion on purchasing Pfizer as a dividend stock for my RRSP and waiting for its recovery? Do you anticipate that it will regain market momentum either this year or sometime next year?

Thank you for your insights!
Read Answer Asked by Esther on March 11, 2024
Q: LEXX on Nasdaq, Lexaria Bioscience Corp, do you have any insight on this company and why it is trending higher of late? Thanks.
Read Answer Asked by Christopher on March 09, 2024
Q: PFE share price is at a low for the past 10 years. It has a low PE with an attractive dividend that pays while you wait. Is the growth profile really that bad that it should be falling out of bed? My suspicion is that in reverting to the mean following the Covid revenue burst the market has overshot and it is unduly punishing the stock. This would represent an excellent buying opportunity, no?
Read Answer Asked by Benjamin on March 08, 2024
Q: Hi team ?

What are your views on Altimmune (ALT-Q) and its growth prospects, its risks ? Would you buy it now for a growth account in a TFSA ? Which entry price would you suggest ?

Gratefully,

Jacques IDS
Read Answer Asked by Jacques on March 06, 2024
Q: Do you see the recent dip in PGNY as an opportunity or did the recent results indicate something worrying? Do you agree with the assessment that there could be long-term, above-average growth possibilities and PGNY is emerging as a leader rather than just simply another OK investment?
Read Answer Asked by John on March 05, 2024
Q: Hi All,

I have a really nice gain shorter term gain on LLY thanks to your recommendation of 125% which is down a little from the high.
Is LLY on the over valued side now and starting to correct? Should I sell it and move into another Healthcare name and if so I'd love a few recommendations. I already own a partial position in UNH and ABBV. I see UNH has dropped and may have some issues with the government should they be stayed away from for now? Thanks for your service.
Read Answer Asked by Harry on March 05, 2024
Q: Would you please give me your evaluation of FLGT's recent quarter. On the surface it appears quite positive, however the stock is down 10%. Was it their guidance that turned the market sour? I am also perplexed - they state they carry $28/share in cash and marketable securities yet the stock is trading at $23 implying that when you strip out cash the business is worth NEGATIVE $148,000,000. Does this mean the market believes something is fundamentally wrong with the business and/or management? Finally, as a shareholder should I be running for the hills or is this a case of the market mispricing an asset?

Many thanks
Scott
Read Answer Asked by Scott on March 01, 2024
Q: Hello, you recommended UnitedHealth Group Inc. (UNH) in the past. The recent launch of an antitrust investigation against UNH has led to a sudden drop in the stock price. I’m curious about your thoughts on this investigation. Do you believe it will cause any damage to the company? And considering the circumstances, do you still consider UNH a good buy? Thank you!
Read Answer Asked by Esther on March 01, 2024
Q: How would you rate ILMN overall since 2024? Is it still a takeover target in your estimation and who would be the top ones that would make most sense to acquire ILMN?
Read Answer Asked by MG on March 01, 2024